Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Jansen

Showing results (1581-1590 of 1,668) with videos related to

Pageof 167
Sort By:
Inflammatory Bowel Diseases|January 9, 2015
Self-reported disability in patients with inflammatory bowel disease largely determined by disease activity and illness perceptionsMike van der Have, Herma H Fidder, Max Leenders, et al.
Inflammatory Bowel Diseases|July 13, 2017
Clinical Predictors of Future Nonadherence in Inflammatory Bowel DiseaseMirjam Severs, Marie-Josée J Mangen, Herma H Fidder, et al.
Journal of Crohn'S & Colitis|September 21, 2016
Smoking is Associated with Higher Disease-related Costs and Lower Health-related Quality of Life in Inflammatory Bowel DiseaseM Severs, M-J J Mangen, M E van der Valk, et al.
Gastroenterology|March 21, 2015
Cost Efficacy of Metal Stents for Palliation of Extrahepatic Bile Duct Obstruction in a Randomized Controlled TrialDaisy Walter, Petra G A van Boeckel, Marcel J Groenen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2020
Changes in Peripheral and Local Tumor Immunity after Neoadjuvant Chemotherapy Reshape Clinical Outcomes in Patients with Breast CancerMargaret L Axelrod, Mellissa J Nixon, Paula I Gonzalez-Ericsson, et al.
Plos One|April 22, 2016
Evolution of Costs of Inflammatory Bowel Disease over Two Years of Follow-UpMirthe E van der Valk, Marie-Josée J Mangen, Mirjam Severs, et al.
Alimentary Pharmacology & Therapeutics|April 3, 2020
Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registryVince B C Biemans, Jasmijn A M Sleutjes, Annemarie C de Vries, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2021
Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast CancerCarmine De Angelis, Xiaoyong Fu, Maria Letizia Cataldo, et al.
Antioxidants (Basel, Switzerland)|August 28, 2025
Causal Inference Approaches Reveal Associations Between LDL Oxidation, NO Metabolism, Telomere Length and DNA Integrity Within the MARK-AGE StudyAndrei Valeanu, Denisa Margina, María Moreno-Villanueva, et al.
Inflammatory Bowel Diseases|February 13, 2014
Effect of aging on healthcare costs of inflammatory bowel disease: a glimpse into the futureMike van der Have, Marie-Josée J Mangen, Mirthe E van der Valk, et al.
Pageof 167

Showing results (1581-1590 of 1,668) with videos related to

Sort By:
Pageof 167
Inflammatory Bowel Diseases|January 9, 2015
Self-reported disability in patients with inflammatory bowel disease largely determined by disease activity and illness perceptionsMike van der Have, Herma H Fidder, Max Leenders, et al.
Inflammatory Bowel Diseases|July 13, 2017
Clinical Predictors of Future Nonadherence in Inflammatory Bowel DiseaseMirjam Severs, Marie-Josée J Mangen, Herma H Fidder, et al.
Journal of Crohn'S & Colitis|September 21, 2016
Smoking is Associated with Higher Disease-related Costs and Lower Health-related Quality of Life in Inflammatory Bowel DiseaseM Severs, M-J J Mangen, M E van der Valk, et al.
Gastroenterology|March 21, 2015
Cost Efficacy of Metal Stents for Palliation of Extrahepatic Bile Duct Obstruction in a Randomized Controlled TrialDaisy Walter, Petra G A van Boeckel, Marcel J Groenen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2020
Changes in Peripheral and Local Tumor Immunity after Neoadjuvant Chemotherapy Reshape Clinical Outcomes in Patients with Breast CancerMargaret L Axelrod, Mellissa J Nixon, Paula I Gonzalez-Ericsson, et al.
Plos One|April 22, 2016
Evolution of Costs of Inflammatory Bowel Disease over Two Years of Follow-UpMirthe E van der Valk, Marie-Josée J Mangen, Mirjam Severs, et al.
Alimentary Pharmacology & Therapeutics|April 3, 2020
Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registryVince B C Biemans, Jasmijn A M Sleutjes, Annemarie C de Vries, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2021
Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast CancerCarmine De Angelis, Xiaoyong Fu, Maria Letizia Cataldo, et al.
Antioxidants (Basel, Switzerland)|August 28, 2025
Causal Inference Approaches Reveal Associations Between LDL Oxidation, NO Metabolism, Telomere Length and DNA Integrity Within the MARK-AGE StudyAndrei Valeanu, Denisa Margina, María Moreno-Villanueva, et al.
Inflammatory Bowel Diseases|February 13, 2014
Effect of aging on healthcare costs of inflammatory bowel disease: a glimpse into the futureMike van der Have, Marie-Josée J Mangen, Mirthe E van der Valk, et al.
Pageof 167